Difference between revisions of "Pirinen E"
From Bioblast
(Created page with "{{Person}}") |
|||
| Line 1: | Line 1: | ||
{{Person}} | {{Person | ||
|lastname=Pirinen | |||
|firstname=Eija | |||
|institution=University of Helsinki | |||
Research Program for Molecular Neurology | |||
University of Helsinki | |||
|address=Yliopistonkatu 4 | |||
|area code=00100 | |||
|city=Helsinki | |||
|country=Finland | |||
}} | |||
{{Labelingperson}} | |||
== Participated at == | |||
* [[IOC106]] | |||
Revision as of 17:29, 13 July 2015
| Name | Pirinen Eija, |
|---|---|
| Institution | University of Helsinki
Research Program for Molecular Neurology University of Helsinki |
| Address | Yliopistonkatu 4, 00100 |
| City | Helsinki |
| State/Province | |
| Country | Finland |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | FI Helsinki Pirinen E |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Van de Weijer 2015 Diabetes | 2015 | van de Weijer T, Phielix E, Bilet L, Williams EG, Ropelle ER, Bierwagen A, Livingstone R, Nowotny P, Sparks LM, Paglialunga S, Szendroedi J, Havekes B, Moullan N, Pirinen E, Hwang JH, Schrauwen-Hinderling VB, Hesselink MK, Auwerx J, Roden M, Schrauwen P (2015) Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. Diabetes 64:1193-201. |
